コロラド州における喘息の臨床試験
コロラド州内の拠点で、喘息に関する18件の研究が参加者を募集しています。
コロラド州内の都市
公式研究テキスト（英語）
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Colorado Springs
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/30更新 · NCT05757102ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Colorado Springs
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/24更新 · NCT07301255Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Research Site, Aurora
被験者募集中第3相
6歳以上 · 全性別 · 2026/09/22更新 · NCT07444567A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Colorado ENT & Allergy, Colorado Springs
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/09/22更新 · NCT06977581A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Asthma & Allergy Associates - Colorado Springs, Colorado Springs
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07219173A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 15, Colorado Springs
被験者募集中第3相
12歳〜80歳 · 全性別 · 2026/09/21更新 · NCT07276724PULmonary Stimulation for Asthma Relief
- National Jewish Health, Denver
被験者募集中
18歳〜75歳 · 全性別 · 2026/09/16更新 · NCT07709754A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12142, Lakewood
被験者募集中第3相
12歳以上 · 全性別 · 2026/08/31更新 · NCT06664619A Study of Depemokimab in Participants of 6 to 11 Years of Age
- GSK Investigational Site, Colorado Springs
被験者募集中第3相
6歳〜11歳 · 全性別 · 2026/08/26更新 · NCT07671001Registry of Asthma Characterization and Recruitment 3 (RACR3)
- Children's Hospital Colorado: Allergy Program, Aurora
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2026/08/21更新 · NCT05272241A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, Aurora
被験者募集中第3相
12歳以上 · 全性別 · 2026/08/17更新 · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Denver
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/08/13更新 · NCT06307665Protocol CAUSE-03 / CHEETAH
- Children's Hospital Colorado: Allergy Program, Aurora
被験者募集中観察研究健康なボランティア歓迎
6歳〜17歳 · 全性別 · 2026/07/01更新 · NCT06136091Individualizing Treatment for Asthma in Primary Care (Full Study)
- DARTNet Institute, Aurora
- University Colorado-Denver, Aurora
被験者募集中第4相
13歳〜75歳 · 全性別 · 2025/10/29更新 · NCT07052942Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
- University of Colorado Anschutz Medical Campus, Aurora
被験者募集中第2相
18歳〜65歳 · 全性別 · 2025/06/10更新 · NCT03762395Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
- National Jewish Health, Denver
被験者募集中第2相
18歳〜70歳 · 全性別 · 2023/04/06更新 · NCT05259904Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
- University of Colorado, Aurora
被験者募集中
18歳〜65歳 · 全性別 · 2023/02/02更新 · NCT03215836Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
- National Jewish Health, Denver
被験者募集中第2相
18歳以上 · 全性別 · 2017/09/14更新 · NCT02947945ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。